<VariationArchive VariationID="226347" VariationName="NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs)" VariationType="Duplication" Accession="VCV000226347" Version="25" RecordType="classified" NumberOfSubmissions="15" NumberOfSubmitters="15" DateLastUpdated="2024-05-01" DateCreated="2016-05-22" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="228160" VariationID="226347">
      <GeneList>
        <Gene Symbol="LDLR" FullName="low density lipoprotein receptor" GeneID="3949" HGNC_ID="HGNC:6547" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11089463" stop="11133820" display_start="11089463" display_stop="11133820" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11200037" stop="11244505" display_start="11200037" display_stop="11244505" Strand="+" />
          </Location>
          <OMIM>606945</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LDLR">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LDLR">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs)</Name>
      <CanonicalSPDI>NC_000019.10:11111568:GGGTGG:GGGTGGGTGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11111568" stop="11111569" display_start="11111568" display_stop="11111569" variantLength="4" positionVCF="11111568" referenceAlleleVCF="A" alternateAlleleVCF="AGGGT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11222247" stop="11222250" display_start="11222247" display_stop="11222250" variantLength="4" positionVCF="11222244" referenceAlleleVCF="A" alternateAlleleVCF="AGGGT" />
      </Location>
      <OtherNameList>
        <Name>FH Nashville</Name>
        <Name>NM_000527.4:c.1121_1122insGTGG</Name>
        <Name>p.Tyr375TrpfsX7</Name>
      </OtherNameList>
      <ProteinChange>Y207fs</ProteinChange>
      <ProteinChange>Y248fs</ProteinChange>
      <ProteinChange>Y334fs</ProteinChange>
      <ProteinChange>Y375fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.11111571_11111574dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.11111571_11111574dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.11222247_11222250dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.11222247_11222250dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009060.1" sequenceAccession="NG_009060" sequenceVersion="1" change="g.27191_27194dup">
            <Expression>NG_009060.1:g.27191_27194dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000527.5" sequenceAccession="NM_000527" sequenceVersion="5" change="c.1118_1121dup" MANESelect="true">
            <Expression>NM_000527.5:c.1118_1121dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000518.1" sequenceAccession="NP_000518" sequenceVersion="1" change="p.Tyr375fs">
            <Expression>NP_000518.1:p.Tyr375fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195798.2" sequenceAccession="NM_001195798" sequenceVersion="2" change="c.1118_1121dup">
            <Expression>NM_001195798.2:c.1118_1121dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182727.1" sequenceAccession="NP_001182727" sequenceVersion="1" change="p.Tyr375fs">
            <Expression>NP_001182727.1:p.Tyr375fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195799.2" sequenceAccession="NM_001195799" sequenceVersion="2" change="c.995_998dup">
            <Expression>NM_001195799.2:c.995_998dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182728.1" sequenceAccession="NP_001182728" sequenceVersion="1" change="p.Tyr334fs">
            <Expression>NP_001182728.1:p.Tyr334fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195800.2" sequenceAccession="NM_001195800" sequenceVersion="2" change="c.614_617dup">
            <Expression>NM_001195800.2:c.614_617dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182729.1" sequenceAccession="NP_001182729" sequenceVersion="1" change="p.Tyr207fs">
            <Expression>NP_001182729.1:p.Tyr207fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195803.2" sequenceAccession="NM_001195803" sequenceVersion="2" change="c.737_740dup">
            <Expression>NM_001195803.2:c.737_740dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182732.1" sequenceAccession="NP_001182732" sequenceVersion="1" change="p.Tyr248fs">
            <Expression>NP_001182732.1:p.Tyr248fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_274" sequenceAccession="LRG_274">
            <Expression>LRG_274:g.27191_27194dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000527.4" sequenceAccession="NM_000527" sequenceVersion="4" change="c.1118_1121dupGTGG">
            <Expression>NM_000527.4:c.1118_1121dupGTGG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10576299" DB="ClinGen" />
        <XRef ID="LDLR_000161" DB="LDLR-LOVD, British Heart Foundation" />
        <XRef Type="Allelic variant" ID="606945.0020" DB="OMIM" />
        <XRef Type="rs" ID="875989916" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs) AND Hypercholesterolemia, familial, 1" Accession="RCV000211651" Version="15">
        <ClassifiedConditionList TraitSetID="7435">
          <ClassifiedCondition DB="MedGen" ID="C0745103">Hypercholesterolemia, familial, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-06-15" SubmissionCount="8">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs) AND Familial hypercholesterolemia" Accession="RCV000588024" Version="9">
        <ClassifiedConditionList TraitSetID="10706">
          <ClassifiedCondition DB="MedGen" ID="C0020445">Familial hypercholesterolemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-03" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs) AND Homozygous familial hypercholesterolemia" Accession="RCV000825618" Version="4">
        <ClassifiedConditionList TraitSetID="48382">
          <ClassifiedCondition DB="MedGen" ID="C0342881">Homozygous familial hypercholesterolemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-02-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs) AND not provided" Accession="RCV002284377" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-09-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000527.5(LDLR):c.1118_1121dup (p.Tyr375fs) AND Cardiovascular phenotype" Accession="RCV002433922" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-03" NumberOfSubmissions="15" NumberOfSubmitters="15" DateCreated="2016-05-22" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10208479</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1301956</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16389549</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17094996</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20809525</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2088165</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22881376</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23680767</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24075752</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28645073</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28964736</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31345425</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31447099</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32041611</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3263645</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32719484</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34297352</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9259195</ID>
        </Citation>
        <DescriptionHistory Dated="2020-09-18">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7435" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15983" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypercholesterolemia, familial, 1</ElementValue>
                <XRef ID="MONDO:0007750" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIA, FAMILIAL, MODIFIER OF</ElementValue>
                <XRef Type="Allelic variant" ID="600946.0028" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LDL RECEPTOR DISORDER</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia Type IIa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPER-LOW-DENSITY-LIPOPROTEINEMIA</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
                <XRef Type="MIM" ID="144400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fredrickson type IIa hyperlipoproteinemia</ElementValue>
                <XRef ID="397915002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyper-beta-lipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia Type II</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FHC</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FH</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/CG71</URL>
                <CitationText>National Institute for Health and Clinical Excellence, Identification and management of familial hypercholesterolaemia, 2008 [Updated: 4 October 2019]</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2012">
                <ID Source="PubMed">22364837</ID>
              </Citation>
              <Citation Type="general" Abbrev="IPMFH, 2004">
                <ID Source="PubMed">15177124</ID>
              </Citation>
              <Citation Type="general" Abbrev="NLAEP, 2011">
                <ID Source="PubMed">21600525</ID>
              </Citation>
              <Citation Type="general" Abbrev="Int'l FH Foundation, 2014">
                <ID Source="PubMed">24418289</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="general" Abbrev="Feldman et al., 2015">
                <ID Source="PubMed">25404096</ID>
              </Citation>
              <Citation Type="general" Abbrev="EAS, 2014">
                <ID Source="PubMed">25053660</ID>
              </Citation>
              <Citation Type="general" Abbrev="PLEF, 2014">
                <ID Source="PubMed">24636176</ID>
              </Citation>
              <Citation Type="general" Abbrev="PLEF, 2013">
                <ID Source="PubMed">23725921</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="391665" DB="Orphanet" />
              <XRef ID="C0745103" DB="MedGen" />
              <XRef ID="MONDO:0007750" DB="MONDO" />
              <XRef Type="MIM" ID="143890" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="48382" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42448" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Homozygous familial hypercholesterolemia</ElementValue>
                <XRef ID="MONDO:0018328" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypercholesterolemia - homozygous</ElementValue>
                <XRef ID="39140541" DB="NCBI for submitter" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10416" />
                <XRef ID="10416" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="391665" DB="Orphanet" />
              <XRef ID="C0342881" DB="MedGen" />
              <XRef ID="MONDO:0018328" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10706" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16649" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial hypercholesterolemia</ElementValue>
                <XRef ID="Familial+Hypercholesterolemia/2746" DB="Genetic Alliance" />
                <XRef ID="MONDO:0005439" DB="MONDO" />
                <XRef ID="398036000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FH</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/CG71</URL>
                <CitationText>National Institute for Health and Clinical Excellence, Identification and management of familial hypercholesterolaemia, 2008 [Updated: 4 October 2019]</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="PLoS Currents, 2011">
                <URL>http://knol.google.com/k/ren%C3%A9e-m-ned/cascade-screening-for-familial/70fnx9tmvdav/13?collectionId=28qm4w0q65e4w.50#</URL>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng238</URL>
                <CitationText>UK NICE Guideline NG238, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <XRef ID="C0020445" DB="MedGen" />
              <XRef ID="MONDO:0005439" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS143890" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="504721" SubmissionDate="2016-05-09" DateLastUpdated="2016-05-22" DateCreated="2016-05-22">
        <ClinVarSubmissionID localKey="NM_000527.4:c.1118_1121dupGTGG|MedGen:C0020445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000268600" DateUpdated="2016-05-22" DateCreated="2016-05-22" Type="SCV" Version="1" SubmitterName="Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA - Fiona Stanley Hospital" OrgID="320268" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-01-31">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dupGTGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>5_9_2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="571283" SubmissionDate="2016-04-20" DateLastUpdated="2018-07-28" DateCreated="2016-07-29">
        <ClinVarSubmissionID localKey="g.11222247_11222250dup" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000295228" DateUpdated="2018-07-28" DateCreated="2016-07-29" Type="SCV" Version="2" SubmitterName="LDLR-LOVD, British Heart Foundation" OrgID="500536" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2088165</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9259195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16389549</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22881376</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACGS Guidelines, 2013</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/zo8lkdib/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_finalpdf.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">2088165</ID>
            </Citation>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">9259195</ID>
            </Citation>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">22881376</ID>
            </Citation>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">16389549</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>FH Nashville</Name>
            <Name>c.1118_1121dup</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606945.0020" Type="Allelic variant" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.11222247_11222250dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020445" Type="CUI" />
          </Trait>
        </TraitSet>
        <StudyDescription>Update of the UCL LDLR variant database, including published reports of variants.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>LDLR_UCL</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1161781" SubmissionDate="2017-04-17" DateLastUpdated="2017-09-09" DateCreated="2017-09-09">
        <ClinVarSubmissionID localKey="g.27191_27194dup" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000599361" DateUpdated="2017-09-09" DateCreated="2017-09-09" Type="SCV" Version="1" SubmitterName="Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge" OrgID="505909" OrganizationCategory="laboratory" OrgAbbreviation="INSA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <CellLine>Homozygous patient fibroblasts</CellLine>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">&lt;2% LDLR activity</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">1301956</ID>
            </Citation>
            <Comment>Assay Description:Hmz patients' fibroblasts, 125I-LDL assays</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000527.4:c.1118_1121dup</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NG_009060.1:g.27191_27194dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2584530</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1525491" SubmissionDate="2018-04-09" DateLastUpdated="2018-07-09" DateCreated="2018-07-09">
        <ClinVarSubmissionID localKey="GL16060|OMIM:143890" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000782908" DateUpdated="2018-07-09" DateCreated="2018-07-09" Type="SCV" Version="1" SubmitterName="Robarts Research Institute, Western University" OrgID="505989" OrganizationCategory="laboratory" OrgAbbreviation="RRI" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1115_1116insGGGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="143890" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3887192</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24046" SubmissionDate="2019-06-19" DateLastUpdated="2019-06-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606945.0020_FH NASHVILLE" title="LDLR, 4-BP INS, EX8_FH NASHVILLE" />
        <ClinVarAccession Accession="SCV000024046" DateUpdated="2019-06-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1988-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an American patient with FH (FHCL1; 143890), Leitersdorf and Hobbs (1990) found insertion of 4 nucleotides in exon 8 causing frameshift and premature termination as the basis of this null allele.</Attribute>
              <Citation>
                <ID Source="PubMed">3263645</ID>
              </Citation>
              <XRef DB="OMIM" ID="143890" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <Name>LDLR, 4-BP INS, EX8</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, EX8</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606945.0020" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FH NASHVILLE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1894764" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="82805778|Orphanet:ORPHA391665" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966970" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1301956</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9259195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16389549</ID>
          </Citation>
          <Comment>The p.Tyr375fs variant has been reported in at least 5 individuals with familial hypercholesterolemia (FH), 4 in the heterozygous state (Day 1997, Humphries 200 6) and 1 in the homozygous state (Hobbs 1992). This variant has also been report ed in ClinVar (Variation ID: 226347). In vitro functional studies provide some e vidence that the p.Tyr375fs variant may impact protein function, resulting in r eceptor activity that &lt;2% compared to wildtype (Hobbs 1992). It has been identif ied in 1/111670 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs875989916). This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 375 and leads to a premature termination codon 7 amino acids downst ream. This alteration is then predicted to lead to a truncated or absent protein . Heterozygous loss of function of the LDLR gene is an established disease mecha nism in individuals with FH. In summary, this variant meets criteria to be class ified as pathogenic for FH in an autosomal dominant manner based upon the presen ce in multiple affected individuals, functional evidence, very low frequency in the general population and the predicted impact to the protein. ACMG/AMP Criteri a applied (Richards 2015): PVS1, PM2, PS4_Moderate, PS3_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000527.4:EXON 8</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_000527.4:c.1121_1122insGTGG</Name>
            <Name>p.Tyr375TrpfsX7</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.11222250_11222251insGTGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Familial hypercholesterolemia - homozygous</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA391665" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1363536" SubmissionDate="2020-02-19" DateLastUpdated="2020-02-21" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="NM_000527.4:c.1118_1121dupGTGG|MedGen:CN118841" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000697184" DateUpdated="2020-02-21" DateCreated="2018-03-17" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">24075752</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">10208479</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">23680767</ID>
          </Citation>
          <Comment>Variant summary: LDLR c.1118_1121dupGTGG (p.Tyr375TrpfsX7) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 251364 control chromosomes. c.1118_1121dupGTGG has been reported in the literature in multiple individuals affected with Familial Hypercholesterolemia (example, Faiz_2013, Vandrovcova_2013, Heath_1999). These data indicate that the variant is likely to be associated with disease. No experimental evidence demonstrating an impact on protein function was ascertained. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="875989916" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dupGTGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN118841" Type="CUI" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2828997" SubmissionDate="2020-09-16" DateLastUpdated="2020-09-19" DateCreated="2020-09-19">
        <ClinVarSubmissionID localKey="NM_000527.4:c.1118_1121dupGTGG" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001432544" DateUpdated="2020-09-19" DateCreated="2020-09-19" Type="SCV" Version="1" SubmitterName="Brunham Lab, Centre for Heart and Lung Innovation, University of British Columbia" OrgID="507262" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>MiSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Citation>
                <ID Source="PubMed">31345425</ID>
              </Citation>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">180416_M04829_0029_000000000-BPB2F:FH008360000_S15:116</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2005-09-06" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Dutch Lipid Clinic Network Criteria score</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">low-density lipoprotein cholesterol level</ElementValue>
                </Name>
              </Trait>
              <Comment>4 (clinical Dutch Lipid Clinic Network Criteria score); 4.63 mmol/L (calculated low-density lipoprotein cholesterol level)</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dupGTGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="143890" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8149309</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3452671" SubmissionDate="2021-07-14" DateLastUpdated="2021-07-24" DateCreated="2021-07-24">
        <ClinVarSubmissionID localKey="NM_000527.4:c.1118_1121dupGTGG|OMIM:143890" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001754785" DateUpdated="2021-07-24" DateCreated="2021-07-24" Type="SCV" Version="1" SubmitterName="Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine" OrgID="500199" OrganizationCategory="laboratory" OrgAbbreviation="HGSC-CL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1118_1121dupGTGG (p.Tyr375Trpfs*7) variant in exon 8 of LDLR gene creates a frameshift and an early stop codon which is predicted to result in an absence of protein product. Loss-of-function variants of LDLR gene are known to cause familial hypercholesterolemia (PMID: 20809525). This variant has been reported in multiple unrelated individuals and families with familial hypercholesterolemia (PMID:301956, 9259195, 16389549, 24075752), but only once in general population database gnomAD. Functional assay of this variant demonstrated that only less than 2% of receptor activity was retained compared to wild type protein (PMID: 1301956). Therefore, the c.1118_1121dupGTGG (p.Tyr375Trpfs*7) variant of LDLR gene is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dupGTGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="143890" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8324489</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5033177" SubmissionDate="2022-09-21" DateLastUpdated="2023-03-04" DateCreated="2022-09-24">
        <ClinVarSubmissionID localKey="GDXSV:240521" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002574653" DateUpdated="2023-03-04" DateCreated="2022-09-24" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Also known as FH Nashville, 11189 insGTGG*, c.1121_1122insGTGG, p.G353fs; This variant is associated with the following publications: (PMID: 31447099, 34040191, 32719484, 32041611, 22881376, 33303402, 2088165, 9259195, 16389549, 23680767, 31345425, 34037665, 24075752, 10208479, 26582918, 1301956)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:692877</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_130_20220921054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5425998" SubmissionDate="2023-12-22" DateLastUpdated="2024-01-06" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="S9506|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002774351" DateUpdated="2024-01-06" DateCreated="2022-12-31" Type="SCV" Version="2" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9259195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16389549</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32041611</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32719484</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31345425</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23680767</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22881376</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10208479</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28964736</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31447099</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1301956</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24075752</ID>
          </Citation>
          <Comment>The LDLR c.1118_1121dup (p.Tyr375Trpfs*7) variant (also known as FH Nashville) variant alters the translational reading frame of the LDLR mRNA and causes the premature termination of LDLR protein synthesis. The frequency of this variant in the general population, 0.0000088 (1/113680 chromosomes, http://gnomad.broadinstitute.org), is consistent with pathogenicity. In the published literature, the variant has been reported in multiple individuals affected with familial hypercholesteremia (PMIDs: 28964736 (2017), 32041611 (2020), 31345425 (2019), 24075752 (2013), 23680767 (2013), 16389549 (2006), 9259195 (1997), 1301956 (1992)). Based on the available information, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12490872</SubmissionName>
          <SubmissionName>SUB14108248</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7132330" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="a5ded026f83223acd705b69d7fea8bf9ec21d0bb3640ad6bc304c5ca3fa53a3c|OMIM:143890" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003827158" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="143890" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8042516" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkf7AR81buf6U8Q7NGk6yIuQ|MedGen:C0020445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004358508" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1301956</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9259195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28964736</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34297352</ID>
          </Citation>
          <Comment>This variant (also known as FH Nashville in literature) inserts 4 nucleotides in exon 8 of the LDLR gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. Cells from a homozygous individual have shown largely reduced (&lt;2% of wild type) LDLR activity (PMID: 1301956). This variant has been reported in at least 6 unrelated individuals affected with familial hypercholesterolemia (PMID: 1301956, 9259195, 28964736, 34297352). This variant has been identified in 1/251364 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of LDLR function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.5:c.1118_1121dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1219209" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1786211|MedGen:C0020445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000627012" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20809525</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28645073</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1301956</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20809525</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24075752</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr375Trpfs*7) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with familial hypercholesterolemia (PMID: 1301956, 20809525, 24075752). This variant is also known as FH Nashville and p.Tyr352fs*7. ClinVar contains an entry for this variant (Variation ID: 226347). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.11222244_11222245insGGGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5233833" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a65500|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002746507" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1301956</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16389549</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17094996</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2088165</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28964736</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9259195</ID>
          </Citation>
          <Comment>The c.1118_1121dupGTGG pathogenic mutation, located in coding exon 8 of the LDLR gene, results from a duplication of 4 nucleotides at positions 1118 to 1121, causing a translational frameshift with a predicted alternate stop codon (p.Y375Wfs*7). This duplication has been reported in several individuals presenting with familial hypercholesterolemia (Hobbs HH et al. Annu Rev Genet. 1990;24:133-70; Tosi I et al. Atherosclerosis 2007;194:102-11; Faiz F et al. Atherosclerosis. 2013;230(2):249-55; Defesche JC et al. J Clin Lipidol Sep;11:1338-1346.e7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.1118_1121dupGTGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2828997" TraitType="Finding" MappingType="Name" MappingValue="Dutch Lipid Clinic Network Criteria score" MappingRef="Preferred">
        <MedGen CUI="None" Name="Dutch Lipid Clinic Network Criteria score" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7132330" TraitType="Disease" MappingType="XRef" MappingValue="143890" MappingRef="OMIM">
        <MedGen CUI="C0745103" Name="Hypercholesterolemia, familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="571283" TraitType="Disease" MappingType="XRef" MappingValue="C0020445" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1525491" TraitType="Disease" MappingType="XRef" MappingValue="143890" MappingRef="OMIM">
        <MedGen CUI="C0745103" Name="Hypercholesterolemia, familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5233833" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24046" TraitType="Disease" MappingType="Name" MappingValue="FH NASHVILLE" MappingRef="Preferred">
        <MedGen CUI="C0745103" Name="Hypercholesterolemia, familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2828997" TraitType="Finding" MappingType="Name" MappingValue="low-density lipoprotein cholesterol level" MappingRef="Preferred">
        <MedGen CUI="None" Name="low-density lipoprotein cholesterol level" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1219209" TraitType="Disease" MappingType="XRef" MappingValue="C0020445" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="504721" TraitType="Disease" MappingType="XRef" MappingValue="C0020445" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5425998" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894764" TraitType="Disease" MappingType="Name" MappingValue="Familial hypercholesterolemia - homozygous" MappingRef="Preferred">
        <MedGen CUI="C0342881" Name="Homozygous familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2828997" TraitType="Disease" MappingType="XRef" MappingValue="143890" MappingRef="OMIM">
        <MedGen CUI="C0745103" Name="Hypercholesterolemia, familial, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8042516" TraitType="Disease" MappingType="XRef" MappingValue="C0020445" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5033177" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1363536" TraitType="Disease" MappingType="XRef" MappingValue="CN118841" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1161781" TraitType="Disease" MappingType="XRef" MappingValue="C0020445" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3452671" TraitType="Disease" MappingType="XRef" MappingValue="143890" MappingRef="OMIM">
        <MedGen CUI="C0745103" Name="Hypercholesterolemia, familial, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

